Efficacy of phosphatidylcholine in the modulation of motion sickness susceptibility.
This study evaluated the efficacy of pharmacological doses of phosphatidylcholine (lecithin) in the modulation of motion sickness induced by exposure to coriolis stimulation in a rotating chair. Subjects received daily dietary supplements of 25 grams of lecithin (90% phosphatidylcholine) and were tested for their susceptibility to motion sickness after 4 h, 2 d, and 21 d. A small but statistically significant increase in susceptibility (+ 15%) was noted 4 h after supplemental phosphatidylcholine, with four of nine subjects demonstrating a marked increase in susceptibility. We attributed this finding to choline's stimulatory action on cholinergic systems, an action which opposes that of the classical antimotion sickness drug scopolamine. Chronic lecithin loading revealed a trend towards reduced susceptibility, possibly indicating the occurrence of adaptive mechanisms such as receptor down-regulation. Withdrawal from lecithin loading, perhaps coupled with anticholinergic treatment, might prove to be a potent prophylactic regimen and ought to be tested.
D003312:Coriolis Force; D004198:Disease Susceptibility; D005260:Female; D006801:Humans; D008297:Male; D009041:Motion Sickness / Q000517:prevention & control*; D010713:Phosphatidylcholines / Q000494:pharmacology*; D013997:Time Factors
D010713:Phosphatidylcholines